Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Abriss

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Human Gene Therapy|August 4, 2010
Transgene loss and changes in the promoter methylation status as determinants for expression duration in nonviral gene transfer for factor IXJörg Schüttrumpf, Peter Milanov, Daniela Abriss, et al.
The FEBS Journal|September 18, 2008
Oxygen-induced changes in hemoglobin expression in DrosophilaEva Gleixner, Daniela Abriss, Boris Adryan, et al.
Blood|October 28, 2011
Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in micePeter Milanov, Lacramioara Ivanciu, Daniela Abriss, et al.
Thrombosis and Haemostasis|November 6, 2009
Factor VIII-eGFP fusion proteins with preserved functional activity for the analysis of the early secretory pathway of factor VIIIStefan Heinz, Jörg Schüttrumpf, Jeremy C Simpson, et al.
Plos One|September 14, 2012
Chemical chaperones improve protein secretion and rescue mutant factor VIII in mice with hemophilia AStefanie D Roth, Jörg Schüttrumpf, Peter Milanov, et al.
Human Gene Therapy. Clinical Development|April 18, 2018
Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous DiseaseChristian Brendel, Michael Rothe, Giorgia Santilli, et al.
Molecular Therapy. Methods & Clinical Development|April 18, 2020
Preclinical Evaluation of a Novel Lentiviral Vector Driving Lineage-Specific BCL11A Knockdown for Sickle Cell Gene TherapyChristian Brendel, Olivier Negre, Michael Rothe, et al.
The New England Journal of Medicine|December 7, 2020
Post-Transcriptional Genetic Silencing of <i>BCL11A</i> to Treat Sickle Cell DiseaseErica B Esrick, Leslie E Lehmann, Alessandra Biffi, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Gene editing without <i>ex vivo</i> culture evades genotoxicity in human hematopoietic stem cellsJing Zeng, My Anh Nguyen, Pengpeng Liu, et al.
Cell Stem Cell|December 13, 2024
Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cellsJing Zeng, My Anh Nguyen, Pengpeng Liu, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Human Gene Therapy|August 4, 2010
Transgene loss and changes in the promoter methylation status as determinants for expression duration in nonviral gene transfer for factor IXJörg Schüttrumpf, Peter Milanov, Daniela Abriss, et al.
The FEBS Journal|September 18, 2008
Oxygen-induced changes in hemoglobin expression in DrosophilaEva Gleixner, Daniela Abriss, Boris Adryan, et al.
Blood|October 28, 2011
Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in micePeter Milanov, Lacramioara Ivanciu, Daniela Abriss, et al.
Thrombosis and Haemostasis|November 6, 2009
Factor VIII-eGFP fusion proteins with preserved functional activity for the analysis of the early secretory pathway of factor VIIIStefan Heinz, Jörg Schüttrumpf, Jeremy C Simpson, et al.
Plos One|September 14, 2012
Chemical chaperones improve protein secretion and rescue mutant factor VIII in mice with hemophilia AStefanie D Roth, Jörg Schüttrumpf, Peter Milanov, et al.
Human Gene Therapy. Clinical Development|April 18, 2018
Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous DiseaseChristian Brendel, Michael Rothe, Giorgia Santilli, et al.
Molecular Therapy. Methods & Clinical Development|April 18, 2020
Preclinical Evaluation of a Novel Lentiviral Vector Driving Lineage-Specific BCL11A Knockdown for Sickle Cell Gene TherapyChristian Brendel, Olivier Negre, Michael Rothe, et al.
The New England Journal of Medicine|December 7, 2020
Post-Transcriptional Genetic Silencing of <i>BCL11A</i> to Treat Sickle Cell DiseaseErica B Esrick, Leslie E Lehmann, Alessandra Biffi, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Gene editing without <i>ex vivo</i> culture evades genotoxicity in human hematopoietic stem cellsJing Zeng, My Anh Nguyen, Pengpeng Liu, et al.
Cell Stem Cell|December 13, 2024
Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cellsJing Zeng, My Anh Nguyen, Pengpeng Liu, et al.
Pageof 1